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Background: Clear cell sarcoma (CCS) and malignant melanoma share overlapping immunohistochemistry with
regard to the melanocytic markers HMB45, S100, and Melan-A. However, the translocation t(12; 22)(q13; q12) is
specific to CCS. Therefore, although these neoplasms are closely related, they are now considered to be distinct
entities. However, the translocation is apparently detectable only in 50%–70% of CCS cases. Therefore, the absence
of a detectable EWS/AFT1 rearrangement may occasionally lead to erroneous exclusion of a translocation-negative
CCS. Therefore, histological assessment is essential for the correct diagnosis of CCS. Primary CCS of the bone is
exceedingly rare. Only a few cases of primary CCS arising in the ulna, metatarsals, ribs, radius, sacrum, and humerus
have been reported, and primary CCS arising in the pubic bone has not been reported till date.
Case presentation: We present the case of an 81-year-old man with primary CCS of the pubic bone. Histological
examination of the pubic bone revealed monomorphic small-sized cells arranged predominantly as a diffuse sheet
with round, hyperchromatic nuclei and inconspicuous nucleoli. The cells had scant cytoplasm, and the biopsy
findings indicated small round cell tumor (SRCT). Immunohistochemical staining revealed the tumor cells to be
positive for HMB45, S100, and Melan-A but negative for cytokeratin (AE1/AE3) and epithelial membrane antigen. To
the best of our knowledge, this is the first case report of primary CCS of the pubic bone resembling SRCT. This
ambiguous appearance underscores the difficulties encountered during the histological diagnosis of this rare
variant of CCS.
Conclusion: Awareness of primary CCS of the bone is clinically important for accurate diagnosis and management
when the tumor is located in unusual locations such as the pubic bone and when the translocation t(12; 22)(q13;
q12) is absent.
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Clear cell sarcoma (CCS) of soft tissue was formerly
known as malignant melanoma of soft tissues because of
the presence of melanin pigmentation and (pre-)melano-
somes in a significant percentage of these tumors. CCS
was originally described by Enzinger in 1965, and it has
become a well-defined clinicopathological entity since
then [1]. CCS and malignant melanoma share overlapping* Correspondence: in1304@poh.osaka-med.ac.jp
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distribution, and reproduction in any mediumimmunohistochemistry with regard to the melanocytic
markers HMB45, S100, and Melan-A. However, CCS gen-
erally lacks melanoma-associated BRAF mutations [2-4].
In addition, the translocation t(12; 22)(q13; q12) is specific
only to CCS [5] and results in fusion of EWS (22q12) and
ATF1 (12q13). Therefore, although these neoplasms are
closely related, they are now considered to be distinct en-
tities. However, the translocation is apparently detectable
only in 50%–70% of CCS cases. Absence of the detect-
able EWS/AFT1 rearrangement may occasionally lead
to erroneous exclusion of a translocation-negative CCS.
Therefore, histological assessment is essential for thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Axial computed tomography of the pelvis
demonstrating a solitary, lytic, expansile lesion in the left
superior pubic ramus.
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http://www.biomedcentral.com/1471-2407/12/538correct diagnosis of CCS [6]. In addition, CCS accounts
for <1% of soft tissue sarcomas, and this tumor is so rare
that there are no standard regimens. It typically involves
tendons and aponeuroses of young adults. Primary CCS
of the bone is exceedingly rare. Only a few cases of pri-
mary CCS arising in the ulna, metatarsals, ribs, radius,
sacrum, and humerus have been reported [7-9], and, to
the best of our knowledge, CCS arising in the pubic
bone has never been reported.
Case presentation
An 81-year-old man presented at our institution with
right-sided groin pain since 2 months. He had no historyFigure 2 (A) Diffuse infiltration of small round cells with inconspicuou
objective magnification, ×40). (B) Abnormal cells positive for HMB45 (ob
(objective magnification, ×40). (D) Abnormal cells positive for Melan-A. (obof trauma, infection, or constitutional symptoms. Radio-
logical examination on first admission revealed an
expanding destructive lesion in the left superior pubic
ramus. A technetium-99 m bone scan demonstrated ac-
tivity in the left superior pubic ramus, and computed
tomography (CT) revealed a mass encasing the left su-
perior pubic ramus (Figure 1). Needle biopsy of the
pubic bone was then performed. Histological examin-
ation of the biopsy specimen revealed monomorphic
small cells arranged predominantly as a diffuse sheet.
The cells had round hyperchromatic nuclei, inconspicu-
ous nucleoli, and scant cytoplasm. These findings were
indicative of small round cell tumor (SRCT; Figure 2A).
On immunohistochemical staining, the tumor cells were
positive for HMB45 (DAKO, Carpenteria, CA, USA;
Figure 2B), S100 (DAKO, Carpenteria, CA; Figure 2C),
and Melan-A (Novocastra, Newcastle-Upon-Tyne, UK;
Figure 2D), whereas they were negative for cytokeratin
(AE1/AE3) and epithelial membrane antigen. Fluores-
cence in situ hybridization analysis of the fusion signal
of EWS located on chromosome 22q12 yielded negative
results. BRAF (exons 11 and 15) mutation analysis by
direct sequencing revealed the absence of mutations
[4]. Although the biopsy specimen showed no obvious
evidence of melanoma pigments, these findings sug-
gested malignant melanoma or CCS. Whole-body CT,
positron emission tomography (PET)/CT, and 67Ga-
citrare scintigraphy were performed to exclude the pos-
sibility of metastases of malignant melanoma to the
bone. The patient was referred to a dermatologist fors nucleoli and scanty cytoplasm (hematoxylin and eosin stain;
jective magnification, ×40). (C) Abnormal cells positive for S100.
jective magnification, ×40).
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All efforts to find a primary lesion elsewhere were un-
successful. Eventually, we concluded that this was not a
metastatic lesion of malignant melanoma but primary
CCS of the pubic bone. Because of the patient’s
advanced age, he and his family refused surgery as well
as local radiation therapy; instead, they opted for
chemotherapy. The patient was administered DAV
chemotherapy (a regimen of dimethyl triazeno imid-
azole carboxamide, 1-[4-amino-2-methyl-5-pyrimidinyl]-
methyl-3-[2-chloroethyl]-3-nitrosourea hydrochloride, the
available substitute for bischloroethylnitrosourea, and
vincristine) [10,11]; however, he died of progressive
disease.Discussion
CCS typically presents a uniform, nested-to-fascicular
growth pattern. Tumor cells are polygonal or spindle-
shaped with abundant cytoplasm. Less common mor-
phologic variations include spindle-cell arrangement,
marked pleomorphism, solid-cell aspect, microcystic as-
pect, and presence of myxoid stroma [12].
SRCT comprises heterogeneous neoplasms comprising
relatively small, round-to-oval, closely-packed, undiffer-
entiated cells with a high nuclear/cytoplasmic ratio,
scant cytoplasm, and round nuclei with evenly distribu-
ted, slightly coarse chromatin and small or inconspicu-
ous nucleoli. SRCT comprises a group of highly
aggressive malignant tumors [13]. Despite the similar
morphology of CSS and SRCT under light microscopic
examination, the latter differs from the former in that it
includes pathological entities from vastly different
lineages, including epithelial tumors such as small-cell
carcinoma (poorly-differentiated neuroendocrine carcin-
oma); mesenchymal tumors such as malignant solid neo-
plasms of childhood and other small round-cell
sarcomas, and tumors with overlapping features such as
lymphoma and melanoma [14]. Small-cell malignant
melanoma with the appearance of SRCT is one of the
recognized rare variants of malignant melanoma, and it
is frequently documented as a complication of congeni-
tal melanocytic nevi [15], as a childhood neoplasm [16],
or as a tumor of mucosal origin [17]. However, CCS re-
sembling SRCT has not been previously reported.
To the best of our knowledge, this is the first case re-
port of primary CCS of the pubic bone resembling
SRCT. This ambiguous appearance underscores the diffi-
culties encountered during the histological diagnosis of
this rare variant of CCS. Awareness of primary CCS of
the bone is clinically important for accurate diagnosis
and management when the tumor is located in unusual
locations such as the pubic bone and when the trans-
location t(12; 22)(q13; q12) is absent.Consent
Written informed consent for publication of data was
obtained from the patient.
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